Patient Experience & Real-World Insights

The need to expedite clinical trial enrollment & completion rates, has always been a key to successful trials. Our robust evidence packages are different and unmatched in the industry utilizing PATIENT integration insights and experiences, real world data and real-world evidence for critical clinical trial and business decisions.

Key Features:

Patient Integration Insights
Incorporate real patient experiences to design trials that are more accessible, engaging, and effective.

Real-World Data (RWD)
Use real-time clinical and behavioral data to guide protocol design and optimize enrollment strategies.

Real-World Evidence (RWE)
Support critical clinical and business decisions with outcome-driven, real-world validation.

Faster Enrollment & Completion
Drive higher recruitment and retention rates with evidence-informed design and patient-first execution.

Differentiated Evidence Packages
Deliver unmatched PIE, RWD, and RWE integration to accelerate development and de-risk investments.

Why Choose Synaptigen?

  • Patient-Centric Design: Our tools are built with patient advocacy at their core, minimizing burdens and prioritizing engagement.

  • Regulatory Expertise: We deliver AI-generated insights that meet rigorous global compliance requirements.

  • Bespoke Solutions: From small biotech to major CROs, we adapt to your unique challenges, ensuring a tailored fit for your operational goals.

Join the future of clinical innovation. Let Synaptigen guide your path to success with smarter, faster, and more efficient solutions driven by AI and automation.

Why Choose Us?

  • Expertise: Our team comprises world-class scientists and modelers with deep experience in MIDD, PBPK, QSP, and AI/ML.

  • Innovation: We stay at the forefront of modeling and simulation technologies to deliver cutting-edge solutions.

  • Collaboration: We work closely with sponsors, regulators, and clinicians to ensure successful outcomes.

  • Impact: Our approaches reduce development risks, accelerate timelines, and improve patient access to life-saving therapies.